Acute Myocardial Infarction: Clinical Trials

47 trials for Acute Myocardial Infarction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed, 11 unknown, 7 terminated, 1 enrolling by invitation. 47 Phase 3, 15 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 347Completed 28, Unknown 11, Terminated 7, Enrolling by invitation 1
Phase 215Completed 9, Unknown 4, Terminated 2

Follow Acute Myocardial Infarction: new trials by email Literature Review of Acute Myocardial Infarction trials Research Report on Acute Myocardial Infarction

Trials (filtered) newest first · largest first

All 47 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Autologous Peripheral Blood Stem Cell injection - Acute Myocardial Infarction
Phase 3UnknownSeoul National Hospital302024-07-152024-12-03
Evaluation in STEMI Patients Using FDY-5301
FDY-5301, Placebo - Acute Myocardial Infarction, STEMI
Phase 3CompletedFaraday Pharmaceuticals, Inc.23512022-05-022025-09-12
Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
Metformin - PreDiabetes, Acute Myocardial Infarction
Phase 3UnknownKarolinska Institutet51602021-12-022024-04-02
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Selatogrel, Placebo - Acute Myocardial Infarction
Phase 3Enrolling by invitationViatris Innovation GmbH250002021-08-142026-10-27
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
Dapagliflozin, Placebo - Acute Myocardial Infarction, Heart Failure
Phase 3CompletedAstraZeneca40172020-12-222025-03-07
A Polypill for Secondary Prevention of Ischemic Heart Disease
Polypill - Acute Myocardial Infarction, ST Elevation Myocardial Infarction
Phase 3UnknownIsfahan University of Medical Sciences12002019-05-202020-10-14
Iron in Patients With Cardiovascular Disease
Ferric carboxymaltose, Saline - Cardiovascular Diseases, Anemia, Iron-deficiency
Phase 3TerminatedDr. med. Mahir Karakas82019-02-282023-12-27
Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
Apixaban Oral Tablet [Eliquis], Warfarin - Acute Myocardial Infarction, Left Ventricular Thrombosis
Phase 3CompletedHadassah Medical Organization402018-01-012021-08-25
Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
Empagliflozin 10 mg, Placebo Oral Tablet - Acute Myocardial Infarction
Phase 3CompletedMedical University of Graz4762017-05-112024-08-22
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
LCZ696 (sacubitril/valsartan), Ramipril, Placebo of LCZ696 - Acute Myocardial Infarction
Phase 3CompletedNovartis Pharmaceuticals56692016-12-092023-06-22
Bivalirudin in Acute Myocardial Infarction
Bivalirudin, heparin - Acute Myocardial Infarction
Phase 3UnknownShenzhen Salubris Pharmaceuticals Co., Ltd.3802016-11-012016-11-28
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients
Lysine Acetilsalicilate, Aspirin - Acute Myocardial Infarction
Phase 2 / Phase 3UnknownFundacion Investigacion Interhospitalaria Cardiovascular602016-10-012016-10-11
Bivalirudin Infusion for Ventricular Infarction Limitation
PPCI, Bivalirudin, Heparin - Acute Myocardial Infarction
Phase 3TerminatedThe Medicines Company782014-12-192018-10-05
Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
Anakinra 100 mg, Placebo - Acute Myocardial Infarction
Phase 2 / Phase 3CompletedVirginia Commonwealth University992014-07-012019-12-18
Ticagrelor for PCI Post Thrombolysis
Ticagrelor, Clopidogrel - Acute Myocardial Infarction
Phase 3CompletedUnity Health Toronto1402014-05-012016-11-22
Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI
Doxycycline, Standard care for STEMI - Vascular Diseases, Cardiovascular Diseases
Phase 2 / Phase 3UnknownRussian Academy of Medical Sciences452014-02-012016-12-13
To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Hearticellgram-AMI - Acute Myocardial Infarction
Phase 3CompletedPharmicell Co., Ltd.902013-09-012026-02-09
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
STENTYS self-apposing stent, VISION balloon-expandable stent - Acute Myocardial Infarction
Phase 3TerminatedStentys3182013-05-012017-04-20
Evaluation of a New Cardiac Biomarker Assay
ARCHITECT STAT High Sensitive Troponin I Assay - Acute Coronary Syndrome, Acute Myocardial Infarction
Phase 3CompletedAbbott Diagnostics Division11012012-06-012015-03-17
Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction
Bare metal Stent plus Paclitaxel Balloon, Bare metal Stent - Acute Myocardial Infarction
Phase 3CompletedFrancisco Javier Goicolea2022012-04-012015-02-06

Showing 20 of 47. Sign in to see all of them.

Narrower conditions

ST Elevation Myocardial Infarction (8)  ·  Myocardial Infarction (6)  ·  Heart Failure (5)  ·  Acute Coronary Syndrome (3)  ·  Cardiovascular Diseases (3)  ·  Non-ST Elevated Myocardial Infarction (3)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)  ·  Ventricular Dysfunction, Left (2)  ·  Ventricular Remodeling (2)  ·  Anemia (1)  ·  Anemia, Iron-Deficiency (1)  ·  Angina, Unstable (1)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)

Broader conditions

Heart Diseases (21)  ·  Cardiovascular Diseases (20)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Vascular Diseases (18)  ·  Pathologic Processes (17)  ·  Myocardial Ischemia (16)  ·  Ischemia (15)  ·  Necrosis (15)  ·  Infarction (14)  ·  Myocardial Infarction (8)  ·  Embolism and Thrombosis (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Metabolic Diseases (2)  ·  Neurologic Manifestations (2)

Interventions

Heparin (3)  ·  Drug-Eluting Stents (2)  ·  Sodium Chloride (2)  ·  bivalirudin (2)  ·  Abciximab (1)  ·  Acetylcysteine (1)  ·  Adenosine (1)  ·  Aspirin (1)  ·  Clopidogrel (1)  ·  Control Groups (1)  ·  Cyclosporine (1)  ·  Doxycycline (1)  ·  Enoxaparin (1)  ·  Gelatin (1)  ·  Immunoglobulins, Intravenous (1)

Sponsors

Abbott Diagnostics Division (1)  ·  Abbott RDx Cardiometabolic (1)  ·  Abiomed Inc. (1)  ·  AstraZeneca (1)  ·  Bharat Biotech International Limited (1)  ·  David Garcia-Dorado (1)  ·  Dr. med. Mahir Karakas (1)  ·  Faraday Pharmaceuticals, Inc. (1)  ·  Francisco Javier Goicolea (1)  ·  French Cardiology Society (1)  ·  Fundacion Investigacion Interhospitalaria Cardiovascular (1)  ·  Gennaro Sardella (1)  ·  Hadassah Medical Organization (1)  ·  Harvard Vanguard Medical Associates (1)  ·  Isfahan University of Medical Sciences (1)

Countries

United States (11)  ·  Italy (8)  ·  Canada (7)  ·  Germany (6)  ·  Netherlands (6)  ·  South Korea (6)  ·  Spain (6)  ·  France (5)  ·  Poland (5)  ·  Sweden (5)  ·  Austria (4)  ·  Israel (4)  ·  Portugal (4)  ·  Australia (3)  ·  Belgium (3)

Top investigators

Alan Maisel, MD (1)  ·  Anna Norhammar, MD, Prof. (1)  ·  Antonio Abbate, MD, PhD (1)  ·  Antonio L Bartorelli, MD (1)  ·  Asim Cheema, MD (1)  ·  Ayhan Erkol, M.D (1)  ·  Azita Hajhossein Talasaz, PharmD,BCPS (1)  ·  David Vivas, MD, PhD (1)  ·  Dirk von Lewinski, Assoc.-Prof. (1)  ·  Dr.A Singh, MBBS, MD (1)  ·  Emilio Di Lorenzo, MD PhD (1)  ·  Evgeny A Pokushalov, MD, PhD (1)

Results publications

PMID 16807414, PMID 17200474, PMID 18779444, PMID 18845667, PMID 19389560, PMID 19539255, PMID 19781402, PMID 19853693, PMID 19910293, PMID 19918189, PMID 20089518, PMID 20129531, PMID 20435202, PMID 20501476, PMID 20961630, PMID 21234920, PMID 21299845, PMID 21304097, PMID 21993999, PMID 22449332, PMID 22503057, PMID 22589297, PMID 22795281, PMID 22814783, PMID 23046599, PMID 23351826, PMID 23453104, PMID 23549644, PMID 24176448, PMID 24431901, PMID 25440792, PMID 25449504, PMID 26709136, PMID 26821623, PMID 28938956, PMID 29322434, PMID 30033595, PMID 30340532, PMID 32122219, PMID 32648087, PMID 34693515, PMID 34758252, PMID 34797725, PMID 36036746, PMID 36082663, PMID 36321459, PMID 36480147, PMID 37125529, PMID 37236318, PMID 37407956

NIH funding

2016 (1), 2019 (1), 2023 (1), R34HL121402 (1)